首页> 外文OA文献 >A Novel mTOR Inhibitor; Anthracimycin for the Treatment of Human Hepatocellular Carcinoma

【2h】

A Novel mTOR Inhibitor; Anthracimycin for the Treatment of Human Hepatocellular Carcinoma

机译：一种新型MTOR抑制剂;用于治疗人肝细胞癌的蒽霉素

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A Novel mTOR Inhibitor; Anthracimycin for the Treatment of Human Hepatocellular Carcinoma [J] . Hayashi Tomoyuki, Yamashita Taro, Okada Hikari, Anticancer Research: International Journal of Cancer Research and Treatment . 2017,第7期

机译：一种新型MTOR抑制剂; 用于治疗人肝细胞癌的蒽霉素
2. Loss of Tuberous Sclerosis Complex 2 (TSC2) as a Predictive Biomarker of Response to mTOR Inhibitor Treatment in Patients with Hepatocellular Carcinoma [J] . Jinhyun Cho, Jeeyun Lee, Jusun Kim, Translational Oncology . 2016,第5期

机译：结节性硬化复合物2（TSC2）的丢失作为肝癌患者对mTOR抑制剂治疗反应的预测生物标志物
3. Sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation: Does mTOR inhibitors association augment toxicity? [J] . PerriconeG., MancusoA., BelliL.S., European journal of gastroenterology and hepatology . 2014,第5期

机译：索拉非尼用于肝移植后复发性肝细胞癌的治疗：mTOR抑制剂联合会增加毒性吗？
4. Phenolic Phytochemicals Derived from Red Pine (Pinus densiflora) Inhibit the Invasion and Migration of SK-Hep-1 Human Hepatocellular Carcinoma Cells [C] . SANG JUN LEE, KI WON LEE, HAENG JEON HUR, Meeting on Cell Signaling World: Signal Transduction Pathways as Therapeutic Targets . 2007

机译：赤松（Pinus densiflora）衍生的酚类植物化学物质抑制SK-Hep-1人肝癌细胞的侵袭和迁移
5. The anti-cancer activities of Paeoniae Radix extracts on human hepatocellular carcinoma cell-line HepG2 and multidrug resistant human hepatocellular carcinoma cell-line R-HepG2 and their action mechanisms. [D] . Li, Lok Yee Mandy. 2004

机译：e药提取物对人肝癌细胞HepG2和多药耐药人肝癌细胞R-HepG2的抗癌活性及其作用机制。
6. Loss of Tuberous Sclerosis Complex 2 (TSC2) as a Predictive Biomarker of Response to mTOR Inhibitor Treatment in Patients with Hepatocellular Carcinoma [O] . Jinhyun Cho, Jeeyun Lee, Jusun Kim, 2016

机译：结节性硬化复合物2（TSC2）的丢失作为肝癌患者对mTOR抑制剂治疗反应的预测生物标志物
7. Combined Treatment with MEK and mTOR Inhibitors is Effective in In Vitro and In Vivo Models of Hepatocellular Carcinoma [O] . Xianqiong Liu, Junjie Hu, Xinhua Song, 2019

机译：用MEK和MTOR抑制剂的组合治疗在体外和体内肝细胞癌中有效

A Novel mTOR Inhibitor; Anthracimycin for the Treatment of Human Hepatocellular Carcinoma

著录项

引文网络

相似文献

相关主题

期刊订阅